|
|
Determinants of IBD-related disability: a cross-sectional survey from the GETAID.
Jenny Tannoury
,
Maria Nachury
,
Carole Martins
,
Melanie Serrero
,
Jerome Filippi
et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (10), pp.1098-1107. ⟨10.1111/apt.16353⟩
Journal articles
hal-03216615v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Cassandra Rayer
,
Maria Nachury
,
Arnaud Bourreille
,
Xavier Roblin
,
Laurent Peyrin-Biroulet
et al.
Journal articles
hal-03980994v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group
Maria Nachury
,
Yoram Bouhnik
,
Mélanie Serrero
,
Jerome Filippi
,
Xavier Roblin
et al.
Journal articles
hal-03038260v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID
Rose Al Bacha
,
Yoram Bouhnik
,
Melanie Serrero
,
Jerome Filippi
,
Xavier Roblin
et al.
Journal articles
hal-04113898v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Should we set-up routine screening for primary sclerosing cholangitis in all IBD patients?
Guillaume Bouguen
,
Miles Peter Sparrow
,
Xavier Roblin
Journal articles
hal-01903476v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease.
Guillaume Bouguen
,
David Laharie
,
Stéphane Nancey
,
Xavier Hebuterne
,
Bernard Flourie
et al.
Journal articles
hal-01138534v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and safety of ustekinumab intensification at 90 Mg every four weeks In Crohn's disease: a multicenter study
Mathurin Fumery
,
Laurent Peyrin-Biroulet
,
Stéphane Nancey
,
Romain Altwegg
,
Cyrielle Gilletta
et al.
Journal articles
hal-02959922v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Loriane Lair-Mehiri
,
Carmen Stefanescu
,
Thibaut Vaysse
,
David Laharie
,
Xavier Roblin
et al.
Journal articles
hal-03287300v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
INFLIXIMAB FOR REFRACTORY ULCERATIVE PROCTITIS
Guillaume Bouguen
,
Xavier Roblin
,
Arnaud Bourreille
,
Laura Feier
,
Jérôme Filippi
et al.
Journal articles
hal-00552545v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fumery
,
Jerome Filippi
,
Vered Abitbol
,
Amelie Biron
,
David Laharie
et al.
Journal articles
hal-03336375v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study
Laura Sirmai
,
Anne-Laure Pelletier
,
Nathalie Gault
,
Camille Zallot
,
Guillaume Bouguen
et al.
Journal articles
hal-03625177v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurelien Amiot
,
Jerome Filippi
,
Vered Abitbol
,
Guillaume Cadiot
,
David Laharie
et al.
Journal articles
hal-02798010v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence and determinants of fatigue in patients with IBD: a cross-sectional survey from the GETAID.
Aurelien Amiot
,
Sayma Chaibi
,
Yoram Bouhnik
,
Melanie Serrero
,
Jerome Filippi
et al.
Journal articles
hal-04052487v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study
Marianne Hupe
,
Pauline Riviere
,
Stephane Nancey
,
Xavier Roblin
,
Romain Altwegg
et al.
Journal articles
hal-02562228v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Detection of Dysplasia or Cancer in 3.5% of Patients with Inflammatory Bowel Disease and Colonic Strictures
Mathurin Fumery
,
Guillaume Pineton De Chambrun
,
Carmen Stefanescu
,
Anthony Buisson
,
Aude Bressenot
et al.
Journal articles
hal-01154234v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence of anti-TNF contraindications in Crohn’s disease: A cross-sectional survey from the GETAID
Aurelien Amiot
,
Philippe Seksik
,
Jean-Marie Reimund
,
Maria Nachury
,
Romain Altwegg
et al.
Journal articles
hal-03690498v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study
Anne-Laure Mallet
,
Guillaume Bouguen
,
Guillaume Conroy
,
Xavier Roblin
,
Jean-Bernard Delobel
et al.
Journal articles
hal-01483854v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients with Inflammatory Bowel Disease
Aurelien Amiot
,
Jean-Charles Grimaud
,
Laurent Peyrin-Biroulet
,
Jérome Filippi
,
Benjamin Pariente
et al.
Journal articles
hal-01278611v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study
Antoine Martin
,
Maria Nachury
,
Laurent Peyrin-Biroulet
,
Yoram Bouhnik
,
Stephane Nancey
et al.
Journal articles
hal-02442530v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils
,
Yoram Bouhnik
,
Pierre Michetti
,
Bernard Flourie
,
Hedia Brixi
et al.
Journal articles
hal-01214012v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparative Real-World Effectiveness of Vedolizumab and Ustekinumab for Patients with Ulcerative Colitis: A GETAID Multicentre Cohort Study
Antoine Meyer
,
Mathurin Fumery
,
Laurent Peyrin-Biroulet
,
Jérôme Filippi
,
Romain Altwegg
et al.
Journal articles
hal-03723440v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease
Sara Tadbiri
,
Maria Nachury
,
Yoram Bouhnik
,
Mélanie Serrero
,
Xavier Hebuterne
et al.
Journal articles
hal-03038348v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparative acceptability of therapeutic maintenance regimens in patients with inflammatory bowel disease: results from the nationwide ACCEPT2 Study.
Anthony Buisson
,
Mélanie Serrero
,
Laurie Orsat
,
Stéphane Nancey
,
Pauline Rivière
et al.
Journal articles
hal-03723436v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|